INSIGHT MM study – a pharmaceutical company-sponsored study in multiple myeloma

Dawn Marie Stull PharmD., BCOP scientific director and lead of INSIGHT MM at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the largest pharmaceutical company-sponsored global observational study of its kind in multiple myeloma.

Dawn Marie Stull Pharm.D., BCOP, is the scientific director and lead of INSIGHT MM at Takeda Oncology. One of the lead authors of the INSIGHT MM study, Dr. Stull is an expert in clinical pharmacy, oncology, hematology, and clinical trial development. With over a decade of experience in the pharmaceutical and healthcare industries, she also has extensive experience in medical affairs.

Liked it? Take a second to support healthprofessionalradio on Patreon!

0 Comments

Leave a Reply

You must be logged in to post a comment.